These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return. Gotanda K; Yokoyama H; Satoh K; Taira N Cardiovasc Drugs Ther; 1989 Aug; 3(4):507-15. PubMed ID: 2488102 [TBL] [Abstract][Full Text] [Related]
11. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels. Minkes RK; Kvamme P; Higuera TR; Nossaman BD; Kadowitz PJ Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of vasodilator effects of the potassium channel openers NIP-121 and levcromakalim in dogs and rats. Yamashita T; Masuda Y; Kawamura N; Fujikura N; Tanaka S Jpn J Pharmacol; 1995 Jun; 68(2):145-52. PubMed ID: 7563971 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the vasodilatation by the K+ channel openers: cromakalim and pinacidil. Rhim BY; Lee WS; Hong KW Jpn J Pharmacol; 1992; 58 Suppl 2():335P. PubMed ID: 1507584 [No Abstract] [Full Text] [Related]
14. Effect of timing of treatment of the glyburide-reversible cardioprotective activity of BMS-180448. Gomoll AW; Roth RA; Swillo RE; Baird AJ; Sargent CS; Behling RW; Malone HJ; Grover GJ J Pharmacol Exp Ther; 1997 Apr; 281(1):24-33. PubMed ID: 9103476 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of K(ATP) openers in ischemic rat hearts treated with a potassium cardioplegic solution. Grover GJ; Sleph PG J Cardiovasc Pharmacol; 1995 Nov; 26(5):698-706. PubMed ID: 8637183 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue. Norman NR; Toombs CF; Khan SA; Buchanan LV; Cimini MG; Gibson JK; Meisheri KD; Shebuski RJ Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325 [TBL] [Abstract][Full Text] [Related]
17. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent. Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs. Uchida W; Hirano Y; Taguchi T; Masuda N; Shirai Y; Satoh N; Takenaka T Eur J Pharmacol; 1994 Nov; 264(3):285-93. PubMed ID: 7698167 [TBL] [Abstract][Full Text] [Related]
19. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle. Venkatesh N; Stuart JS; Lamp ST; Alexander LD; Weiss JN Circ Res; 1992 Dec; 71(6):1324-33. PubMed ID: 1423930 [TBL] [Abstract][Full Text] [Related]
20. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs. Giudicelli JF; la Rochelle CD; Berdeaux A J Pharmacol Exp Ther; 1990 Nov; 255(2):836-42. PubMed ID: 2173761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]